COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,243 Articles (22,733 medRxiv, 8,510 bioRxiv)

Most recent first Previous |  Page 2755: Articles 27541-27550  | Next

When strong mitigation against a pandemic backfires
Chaigneau, P.
10.1101/2020.05.13.20100628 — Posted: 2020-05-19
Making sense of publicly available data on COVID-19 in Ireland
Mills, G., Cullen, W., Moore, N., Foley, R.
10.1101/2020.05.13.20101089 — Posted: 2020-05-19
Detecting the Emergent or Re-Emergent COVID-19 Pandemic in a Country: Modelling Study of Combined Primary Care and Hospital Surveillance
Wilson, N., Schwehm, M., Verrall, A. J., Parry, M., Baker, M. G., Eichner, M.
10.1101/2020.05.13.20100743 — Posted: 2020-05-19
Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network
Singh, S., Khan, A., Chowdhry, M., Chatterjee, A.
10.1101/2020.05.12.20099028 — Posted: 2020-05-19
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva
Iwasaki, S., Fujisawa, S., Nakakubo, S., Kamada, K., Yamashita, Y., Fukumoto, T., Sato, K., Oguri, S., Taki, K., Senjo, H., Hayasaka, K., Konno, S., Nishida, M., Teshima, T.
10.1101/2020.05.13.20100206 — Posted: 2020-05-19
Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center
Rimland, C. A., Morgan, C. E., Bell, G. J., Kim, M. K., Hedrick, T., Marx, A., Bramson, B., Napravnik, S., Schmitz, J. L., Carson, S. S., Fischer, W. A., Eron, J. J., Gay, C. L., Parr, J. B.
10.1101/2020.05.13.20100404 — Posted: 2020-05-19 Discussion: Offsite
Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis
Bellou, V., Tzoulaki, I., Evangelou, E., Belbasis, L.
10.1101/2020.05.13.20100495 — Posted: 2020-05-19
COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis
Baker, K. F., Hanrath, A. T., Schim van der Loeff, I., Tee, S. A., Capstick, R., Marchitelli, G., Li, A., Barr, A., Eid, A., Ahmed, S., Bajwa, D., Mohammed, O., Alderson, N., Lendrem, C., Lendrem, D., COVID-19 Control Group, , COVID-19 Clinical Group, , Pareja-Cebrian, L., Welch, A., Field, J., Payne, B. A. I., Taha, Y., Price, D. A., Gibbins, C., Schmid, M. L., Hunter, E., Duncan, C. J. A.
10.1101/2020.05.14.20100834 — Posted: 2020-05-19
Disparities in COVID-19 Reported Incidence, Knowledge, and Behavior
Cutler, D., Stantcheva, S., Alsan, M., Yang, D.
10.1101/2020.05.15.20095927 — Posted: 2020-05-19
The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany
Gandjour, A.
10.1101/2020.05.12.20098996 — Posted: 2020-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).